The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer.
 
James Patrick Buteau
No Relationships to Disclose
 
Daniel Moon
Consulting or Advisory Role - Device Technologies
 
Michael T Fahey
No Relationships to Disclose
 
Matthew Roberts
No Relationships to Disclose
 
James Thompson
No Relationships to Disclose
 
Declan G. Murphy
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; Ipsen; Janssen Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer Schering Pharma; Janssen Oncology
Travel, Accommodations, Expenses - Device Technologies
 
Nathan Papa
No Relationships to Disclose
 
Catherine Mitchell
No Relationships to Disclose
 
Veeru Kasivisvanathan
No Relationships to Disclose
 
Phillip Stricker
Consulting or Advisory Role - Angiodynamics
Research Funding - Angiodynamics (Inst)
 
Jonathan O'Brien
No Relationships to Disclose
 
William Counter
No Relationships to Disclose
 
Gaurav Sharma
No Relationships to Disclose
 
Shikha Agrawal
No Relationships to Disclose
 
Bao Ho
No Relationships to Disclose
 
Theresa Yeung
No Relationships to Disclose
 
Richard De Abreu Lourenço
Consulting or Advisory Role - Vifor Pharma (I)
 
Haryana M. Dhillon
Honoraria - BMS (Inst)
Consulting or Advisory Role - Janssen Oncology (Inst)
 
Michael S Hofman
Consulting or Advisory Role - Endocyte; Janssen; POINT Biopharma
Speakers' Bureau - Astellas Pharma; AstraZeneca; Janssen; Mundipharma
Research Funding - Advanced Accelerator Applications/Novartis (Inst); Bayer (Inst); Endocyte (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen
 
Louise Emmett
Honoraria - Astellas Pharma; AstraZeneca; Janssen Oncology; Mundipharma; Telix Pharmaceuticals
Consulting or Advisory Role - Noxopharm
Speakers' Bureau - Janssen Oncology; Janssen Oncology; mundipharma
Research Funding - Novartis (Inst); Novartis (Inst); Noxopharm (Inst); Noxopharm (Inst)